Insulin-like growth factor-I receptors in normal appearing white matter and chronic plaques in multiple sclerosis

Brain Research

Volumn 772, Issue 1-2, 1997, Pages 243-246

  Wilczak, Nadine ^a   De Keyser, Jacques ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Astrogliosis; Insulin like growth factor I; Insulin like growth factor I receptor; Multiple sclerosis; Myelination

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MITOGENIC AGENT; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

AGED; ARTICLE; ASTROCYTOSIS; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; MALE; MULTIPLE SCLEROSIS; MYELINATION; NEUROPROTECTION; OLIGODENDROGLIA; PRIORITY JOURNAL; RECEPTOR DENSITY; REMYELINIZATION; SENILE PLAQUE; WHITE MATTER;

AGED; BINDING, COMPETITIVE; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RADIOLIGAND ASSAY; RECEPTOR, IGF TYPE 1;

EID: 0030727336     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00940-2     Document Type: Article

References (16)

1. Baron Van Evercooren A., Olichon Berthe C., Kowalski A., Visciano G., Van Obberghen E. Expression of IGF-I and insulin receptor genes in the rat central nervous system: a developmental, regional, and cellular analysis. J. Neurosci. Res. 28:1991;244-253.
2. Barres B.A., Hart I.K., Coles H.S.R., Burne J.F., Voyvodic J.T., Richardson W.D., Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:1992;31-46.
3. Beck K.D., Powell-Braxton L., Widmer H.-R., Valverde J., Hefti F. Mice homozygous for disrupted insulin-like growth factor I gene display reduced myelination in the CNS and reduced numbers of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14:1995;717-730.
4. Carson M.J., Behringer R.R., Brinster R.L., McMorris F.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 10:1993;729-740.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
6. De Keyser J., Wilczak N., Herroelen L., Goossens A. Insulin-like growth factor I receptors in human frontal cortex and white matter during aging, in Alzheimer's disease and in Huntington's disease. Neurosci. Lett. 175:1994;17-20.
7. De Keyser J., Wilczak N., De Backer J.-P., Herroelen L., Vauquelin G. Insulin-like growth factor-I receptors in human brain and pituitary gland: an autoradiographic study. Synapse. 17:1994;196-202.
8. Lassman H., Wisniewski H. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Arch. Neurol. 36:1979;490-497.
9. Liu X., Yao D.-L., Webster HdeF. Insulin-like growth factor-I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis. Multiple Sclerosis. 1:1995;2-9.
10. Lord A.P., Bastian S.E., Read L.C., Walton P.E., Ballard F.J. Differences in the association of insulin-like growth factor-I (IGF-I) and IGF-I variants with rat, sheep, pig, human and chicken plasma-binding proteins. J. Endocrinol. 140:1994;475-482.
11. McMorris F.A., Mozell R.L., Carson M.J., Shinar Y., Meyer R.D., Marchetti N. Regulation of oligodendrocyte development and central nervous system myelination by Insulin-like growth factors. Ann. NY Acad. Sci. 692:1993;321-334.
12. Mozell R.L., McMorris F.A. Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J. Neurosci. Res. 30:1991;382-390.
13. Reinhardt R.R., Bondy C.A. Insulin-like growth factors cross the blood-brain-barrier. Endocrinology. 135:1994;1753-1761.
14. Sobel R.A. The pathology of multiple sclerosis. Neurol. Clin. 13:1995;1-21.
15. Tranque P.A., Calle R., Naftolin F., Robbins R. Involvement of protein kinase-C in the mitogenic effect of insulin-like growth factor-I on rat astrocytes. Endocrinology. 131:1992;1948-1954.
16. Yao D.-L., Liu X., Hudson L.D., Webster HdeF. Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis. Life Sci. 58:1996;1301-1306.